Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Chest

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/CHEST.125.4.1413PMID 15078754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Value of FDG-PET in the management of non-small cell lung cancer.

  2003cited by this paper
• Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy.

  2003cited by this paper
• Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

  2003cited by this paper
• The role of neoadjuvant chemotherapy in marginally resectable or unresectable stage III non-small cell lung cancer.

  2002cited by this paper
• The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.

  2002cited by this paper
• Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.

  2002cited by this paper
• PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.

  2001cited by this paper
• Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging.

  2001cited by this paper
• Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.

  2001cited by this paper
• Role of multimodality treatment for lung cancer.

  2000cited by this paper
• Is there a role for routine mediastinoscopy in patients with peripheral T1 lung cancers?

  2000cited by this paper
• Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.

  2000cited by this paper
• The current role of mediastinoscopy in the evaluation of thoracic disease.

  1999cited by this paper
• Positron emission tomography in lung cancer.

  1998cited by this paper
• Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

  1998cited by this paper
• Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.

  1998cited by this paper
• Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan.

  1997cited by this paper
• Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours?

  1994cited by this paper
• Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer.

  1994cited by this paper
• Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.

  1992cited by this paper
• Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance.

  1988cited by this paper
• Evaluation of the mediastinum by invasive techniques.

  1987cited by this paper
• American Thoracic Society. Medical section of the American Lung Association. Clinical staging of primary lung cancer.

  1983cited by this paper

• Synthetic 18F labeled biomolecules that are selective and promising for PET imaging: major advances and applications.

  2024cites this paper
• Correlation analysis between unenhanced and enhanced CT radiomic features of lung cancers presenting as solid nodules and their efficacy for predicting hilar and mediastinal lymph node metastases

  2022cites this paper
• Role of Positron Emission Tomography in Staging Lymph Nodes in Non-small Cell Lung Cancer

  2022cites this paper
• Cancer of the Lung

  2020cites this paper
• Perforation of small intestine secondary to metastatic lung adenocarcinoma

  2018cites this paper
• Te impact of 18F-FDG PET/CT in staging of non-small cell lung cancer patients: the key to improve patient treatment strategy

  2016cites this paper
• Asymptomatic Duodenal Metastasis From Small Cell Lung Cancer Diagnosed by Endoscopic Ultrasound-Guided Fine-Needle Aspiration

  2016cites this paper
• Staging of Lung Cancer

  2016cites this paper
• Staging, Restaging and Response Evaluation of Non-Small-Cell Lung Cancer

  2015cites this paper
• Abnormal FDG Uptake in the Pericardial Adipose Tissue Mimicking Malignancy

  2015cites this paper
• Dosimetric evaluation of the feasibility of stereotactic body radiotherapy for primary lung cancer with lobe-specific selective elective nodal irradiation

  2015cites this paper
• Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer

  2015cites this paper
• ACR Appropriateness Criteria non-invasive clinical staging of bronchogenic carcinoma.

  2014cites this paper
• Thoracoscopic anatomic pulmonary resection for locally advanced non-small cell lung cancer.

  2014cites this paper
• New CT criteria for nodal staging in non-small cell lung cancer.

  2014cites this paper
• Cancer of the Lung: Non–Small Cell Lung Cancer and Small Cell Lung Cancer

  2014cites this paper
• Diagnostic imaging in the preoperative management of lung cancer

  2014cites this paper
• Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer

  2014cites this paper
• Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer , 3 rd ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2013cites this paper
• Measurements of tumor size using CT and PET compared to histopathological size in non-small cell lung cancer.

  2013cites this paper
• Imaging in Non-small Cell Lung Cancer

  2013cites this paper
• Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cites this paper
• Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer , 3 rd ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2013cites this paper
• Colonic metastasis from primary lung adenocarcinoma: case report and review of the literature

  2012cites this paper
• Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients

  2012cites this paper
• The value of mediastinoscopy in the management of thoracic disease

  2012cites this paper
• Use of Positron Emission Tomography in Initial Staging of Nonsmall Cell Lung Carcinoma: A Regional Teaching Hospital Experience

  2012cites this paper
• A prediction model for N2 disease in T1 non-small cell lung cancer.

  2012cites this paper
• A Metastatic Jejunal Tumor from Squamous Cell Carcinoma of the Lung Found in an Intestinal Perforation

  2011cites this paper
• FDG Uptake and the Diagnostic Yield of Transbronchial Needle Aspiration

  2011cites this paper
• The Challenge of Mediastinal Staging

  2011cites this paper
• MSCT multi-criteria: a novel approach in assessment of mediastinal lymph node metastases in non-small cell lung cancer.

  2011cites this paper
• Combined transbronchial needle aspiration and PET/CT for mediastinal staging of lung cancer.

  2011cites this paper
• Positronen-Emissionstomographie (PET) und PET-CT für die Therapieentscheidung in der Onkologie

  2011cites this paper
• Positronen-Emissionstomographie (PET) und PET-CT für die Therapieentscheidung in der Onkologie

  2011cites this paper
• Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.

  2011cites this paper
• Bilan d’extension du cancer bronchique par la tomographie à émission de positons au 18-fluorodéoxyglucose (FDG-TEP)

  2010cites this paper
• Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC)

  2010cites this paper
• Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

  2010cites this paper
• Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches

  2010cites this paper
• Occult nodal metastasis in patients with non‐small cell lung cancer at clinical stage IA by PET/CT

  2010cites this paper
• Bronchoscopic needle aspiration in the diagnosis of mediastinal lymphadenopathy and staging of lung cancer.

  2010cites this paper
• Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging.

  2010cites this paper
• [What is the role of FDG-PET in thoracic oncology in 2010?].

  2010cites this paper
• Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening

  2009influential citation
• Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer.

  2009cites this paper
• Incidental PET/CT findings in the cancer patient: how should they be managed?

  2009cites this paper
• Accuracy of helical computed tomography for the identification of lymph node metastasis in resectable non-small cell lung cancer

  2008cites this paper
• Molecular imaging: reporter gene imaging.

  2008cites this paper
• Assessing short-term effects and costs at an early stage of innovation: The use of positron emission tomography on radiotherapy treatment decision making

  2008cites this paper
• [The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].

  2008cites this paper
• Ensuring the right PET scan for the right patient.

  2008cites this paper
• Fluorodeoxyglucose positron emission tomography integrated with computed tomography to determine resectability of primary lung cancer

  2008cites this paper
• Curriculum Vitae Personal Data

  2008cites this paper
• Does video-mediastinoscopy improve the results of conventional mediastinoscopy?

  2008cites this paper
• Prognostic value of FDG uptake in early stage non-small cell lung cancer.

  2008cites this paper
• Mediastinal Lymph Node Dissection Affects Survival in Patients with Stage I Non-Small Cell Lung Cancer

  2008cites this paper
• Staging non-small cell lung cancer*

  2007cites this paper
• Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.

  2007cites this paper
• Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6

  2007cites this paper
• Lung cancer.

  2007cites this paper
• Is 18F FDG PET-CT cost effective in lung cancer?

  2007cites this paper
• Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).

  2007cites this paper
• dvances in positron emission tomography technology ave increased the need for surgical staging in non – small ell lung cancer

  2007cites this paper
• Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.

  2006cites this paper
• Multi-modality molecular imaging of tumors.

  2006cites this paper
• Two cases of pulmonary paragonimiasis on FDG-PET CT imaging

  2006cites this paper
• Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using68Ga-DOTATOC PET and comparison with18F-FDG PET

  2006cites this paper
• 18FDG PET in oncology: the best and the worst (Review).

  2006cites this paper
• The Future in Diagnosis and Staging of Lung Cancer: Positron Emission Tomography

  2006cites this paper
• Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer.

  2006cites this paper
• Cancro do pulmão de não pequenas células: Comparação entre o estadiamento clínico e o patológico

  2006cites this paper
• Financial Aspects of Lung Cancer

  2006cites this paper
• Combined transbronchial needle aspiration and positron emission tomography for mediastinal staging of NSCLC

  2006cites this paper
• Combinación de la aspiración transbronquial con aguja y la tomografía por emisión de positrones para la estadificación mediastínica del cáncer de pulmón de células no pequeñas (NSCLC)

  2006cites this paper
• New horizons in staging for non-small-cell lung cancer.

  2006cites this paper
• 肺癌の縦隔リンパ節転移診断に対するFDG-PETと縦隔鏡・胸腔鏡検査の比較

  2006cites this paper
• CT and PET imaging in non-small cell lung cancer.

  2006cites this paper
• Gastro-intestinal metastasis of primary lung carcinoma: clinical presentations and outcome.

  2006cites this paper
• [Non small cell lung cancer - comparison between clinical and pathological staging].

  2006cites this paper
• Functional imaging in lung cancer.

  2005cites this paper
• Evaluation of N parameter in the staging of non-small cell lung cancer: role of CT and PET.

  2005cites this paper
• Molecular Imaging of Lung Cancer

  2005cites this paper
• Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings.

  2005cites this paper
• Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer

  2005cites this paper
• Cost effectiveness of positron emission tomography in Canada.

  2005cites this paper
• Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.

  2005cites this paper
• Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.

  2005cites this paper
• [Use of positron-emission tomography with F18-fluorodeoxyglucose for the assessment of lung lesions suspicious of malignancy].

  2005cites this paper
• Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less.

  2005cites this paper
• Combined mediastinal node assessment by lymphadenectomy and intraoperative mediastinoscopy.

  2005cites this paper
• Positron emission tomography: clinical applications in oncology. Part 1

  2005cites this paper
• Uso de la tomografía de emisión de positrones PET con F18-FDG en la evaluación de lesiones pulmonares sospechosas de neoplasia

  2005cites this paper
• Tomografía por emisión de positrones y tomografía computada (PET-CT)

  2005cites this paper
• Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

  2003cites this paper
• FUNCTIONAL IMAGING IN THE MANAGEMENT OF LUNG CANCER

  year unknowncites this paper